1,161
Participants
Start Date
September 1, 2026
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2028
EVOLV-Rx dashboard
Using the TheraDoc® platform, the investigators will deploy a custom-designed EVOLV-Rx dashboard that incorporates all 18 components of the EVOLV-Rx metric. \[Within TheraDoc®, the dashboard will display an automated report in the form of a patient list that includes the names, locations, and specific LVP practices to which Veterans under their care are subject. Pharmacists will then query specific patients on the list as part of their required medication review. The dashboard will provide detailed clinical decision support by identifying the specific EVOLV-Rx LVP criteria met by each flagged medication and provide access to the patient's full medication list, problem list, and laboratory or testing data contained within VISTA.\] Pharmacists may use the EVOLV-Rx dashboard to track Veterans' receipt of LVP practices and quickly document actions related to the intervention, such as patient and family caregiver engagement, deprescribing LVP practices, or any other medications discontinued.
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
VA Office of Research and Development
FED